Employees: 01 (2023.0)Legal category: 5485Size: PMECreation date: 2005-02-01 (21 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LE PONT-DE-CLAIX (38800), Isere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE FALLIEX VERA : revenue, balance sheet and financial ratios
PHARMACIE FALLIEX VERA is a French company
founded 21 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LE PONT-DE-CLAIX (38800),
this company of category PME
shows in 2022 a revenue of 808 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE FALLIEX VERA (SIREN 481054930)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
808 044 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
-480 696 €
1 249 €
5 672 €
9 822 €
5 190 €
25 669 €
20 080 €
40 375 €
46 498 €
68 845 €
EBITDA
N/C
N/C
N/C
1 097 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
1.2%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE FALLIEX VERA records a net loss of 481 k€. This deficit will reduce equity on the balance sheet.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-480 696 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 82%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
0.493%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
81.592%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE FALLIEX VERA
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
9.539
1.672
3.356
2.777
2.492
2.378
2.281
2.083
2.884
0.493
Financial autonomy
83.582
89.095
89.66
90.506
89.104
86.831
86.128
89.576
90.121
81.592
Repayment capacity
None
None
None
None
None
None
-27.505
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
-0.091%
None%
None%
None%
Sector positioning
Debt ratio
0.492025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Excellent
In 2025, the debt ratio of PHARMACIE FALLIEX VERA (0.49) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
81.59%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Excellent+7 pts over 3 years
In 2025, the financial autonomy of PHARMACIE FALLIEX VERA (81.6%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 216.93. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
216.931
Liquidity indicators evolution PHARMACIE FALLIEX VERA
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
47.483
49.525
116.091
128.831
153.673
146.953
151.696
179.287
208.377
216.931
Interest coverage
None
None
None
None
None
None
3.737
None
None
None
Sector positioning
Liquidity ratio
216.932025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good+16 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE FALLIEX VERA (216.93) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE FALLIEX VERA
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
-44 782 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
9
0
0
0
Customer payment term (days)
0
0
0
0
0
0
4
0
0
0
Supplier payment term (days)
0
0
0
0
0
0
27
0
0
0
Positioning of PHARMACIE FALLIEX VERA in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE FALLIEX VERA with other companies in the same sector:
Frequently asked questions about PHARMACIE FALLIEX VERA
What is the revenue of PHARMACIE FALLIEX VERA ?
The revenue of PHARMACIE FALLIEX VERA in 2022 is 808 k€.
Is PHARMACIE FALLIEX VERA profitable?
PHARMACIE FALLIEX VERA recorded a net loss in 2025.
Where is the headquarters of PHARMACIE FALLIEX VERA ?
The headquarters of PHARMACIE FALLIEX VERA is located in LE PONT-DE-CLAIX (38800), in the department Isere.
Where to find the tax return of PHARMACIE FALLIEX VERA ?
The tax return of PHARMACIE FALLIEX VERA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE FALLIEX VERA operate?
PHARMACIE FALLIEX VERA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart